All In Biotech

Drug Trial Radar · NCT07287644

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

A Phase 2, Dose Ranging, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients With Moderate to Severe Hidradenitis Suppurativa

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 210 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

210

Planned (sponsor's estimate)

Start

Nov 3, 2025

Primary completion

Aug 1, 2027

Study completion Aug 1, 2027

Sponsor

Lead sponsor
Bluefin Biomedicine, Inc.Industry
Sponsor type
Industry
First posted
Dec 17, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.

Conditions

  • Hidradenitis Suppurativa (HS)

Interventions

  • BFB759Biological

    BFB759 is a human mAb that inhibits multiple pro-inflammatory cytokines that contribute to the pathogenesis of multiple disease processes characterized by aberrant inflammation, including hidradenitis suppurativa.

  • Placebo for BFB759Other

    Placebo for BFB759

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of BFB759 in HSTime frame: Baseline to Week 16 and baseline to Week 32

Locations

64 sites in 7 countries. Site status is shown where the registry gives one.

  • Saguaro Dermatology

    Phoenix, Arizona

  • Encino Research Center

    Encino, California

  • Marvel Clinical Research LLC

    Huntington Beach, California

  • Clinical Science Institute

    Santa Monica, California

  • Skin Care Research

    Boca Raton, Florida

  • Center for Skin Science and Innovation

    Fort Lauderdale, Florida

  • Gsi Clinical Research

    Margate, Florida

  • Ziaderm Research LLC

    North Miami Beach, Florida

  • Clinical Trials Management, LLC

    Tampa, Florida

  • DelRicht Research

    Atlanta, Georgia

  • Southeast Research Specialist LLC

    Douglasville, Georgia

  • The Indiana Clinical Trials Center, PC

    Plainfield, Indiana

  • DS Research of Kentucky

    Louisville, Kentucky

  • Martha Stewart

    Mandeville, Louisiana

  • Clinical Trials Management, LLC

    Metairie, Louisiana

  • DelRicht Research

    New Orleans, Louisiana

  • Oakland Hills Dermatology

    Auburn Hills, Michigan

  • MI Skin Innovations

    Northville, Michigan

  • DelRicht Research

    Wildwood, Missouri

  • JDR Dermatology Research LLC

    Las Vegas, Nevada

  • Skin Cancer and Dermatology Institute

    Reno, Nevada

  • Schweiger Dermatology, PC

    Hackensack, New Jersey

  • Equity Medical LLC

    The Bronx, New York

  • Optima Research - Boardman

    Boardman, Ohio

  • Apex Clinical Research Center, LLC

    Canton, Ohio

  • Apex Clinical Research Center, LLC

    Mayfield Heights, Ohio

  • UPMC Department of Dermatology

    Pittsburgh, Pennsylvania

  • Medical Univ of SC Department of Dermatology

    Charleston, South Carolina

  • DelRicht Research

    Mt. Pleasant, South Carolina

  • DelRicht Research

    Smyrna, Tennessee

  • Dermatology Treatment & Research Center

    Dallas, Texas

  • VAST Clinical Research LLC

    Frisco, Texas

  • DelRicht Research

    Prosper, Texas

  • Stryde Research-Epiphany Dermatology

    Southlake, Texas

  • Dermatology Specialists of Spokane

    Spokane, Washington

  • Medical Center Medconsult Burgas EOOD

    Burgas, Bulgaria

  • Medical Center Medconsult Pleven-Lovech Branch

    Lovech, Bulgaria

  • Medical Center Medconsult Pleven OOD

    Pleven, Bulgaria

  • Medical Center Etika Ambulatory For Specialized Outpatient Medical Care OOD

    Plovdiv, Bulgaria

  • Medical Center Rusemed

    Rousse, Bulgaria

Showing 40 of 64 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.